標的放射線療法のスタートアップ企業であるスイスのヌクリディウム(Nuclidium)は10日、シリーズBの資金調達で7,900万スイスフラン(8,400万ユーロ)を確保したと発表した。診断・治療薬の開発と…
標的放射線療法のスタートアップ企業であるスイスのヌクリディウム(Nuclidium)は10日、シリーズBの資金調達で7,900万スイスフラン(8,400万ユーロ)を確保したと発表した。診断・治療薬の開発と…
Cookie | 期間 | 説明 |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |